Biomason

Biomason

We build with carbon the same way nature does. Biocement will reduce 25% of the concrete industry's emissions by 2030.

Founded 2012

United States 67 employees Series C Total: $94.95M Biotechnology, Industrial +1

Biomason is a biotechnology startup founded in 2012 in the United States, with a mission to revolutionize construction by reducing carbon emissions. The company's slogan, "We build with carbon the same way nature does," encapsulates its innovative approach. Biomason is dedicated to addressing the environmental impact of the concrete industry by introducing biocement as a sustainable alternative. Their ambitious goal is to reduce 25% of the global concrete industry's carbon emissions by 2030. Their recent Series C investment of $65.00M on 28 February 2022 indicates notable investor interest. This round of funding was led by Novo Holdings, with participation from 2150, Celesta Capital, Hartree Partners, and Martin Marietta. Biomason's commitment to planetary well-being and disruptive innovation positions it as a compelling venture capital investment opportunity. The company's strategic focus on sustainability and its significant financial backing make it a promising player in the industrial and biotechnology sectors. As the global community prioritizes environmentally friendly practices, Biomason's biocement stands out as a pioneering solution to mitigate the construction industry's carbon footprint. With robust investor support and an impactful mission, Biomason is poised for substantial growth and influence in the years to come. #BuildBetter.

Funding Stage	Amount	Investors	Lead Investors	Date
Series C	$65.00M	5	Novo Holdings, 2150 +3	28 Feb 2022
Venture Round	$23.00M	-		10 Dec 2019
Debt Financing	$3.40M	-		03 May 2017
Seed Round	$1.50M	1	Acorn Innovestments	23 Dec 2015
Grant	$1.37M	1	National Science Foundation	21 Aug 2015
Grant	$179.92K	1	National Science Foundation	20 Dec 2013
Seed Round	$500.00K	-		09 Sep 2013

Funding Stage

Amount

Investors

Lead Investors

Date

Series C

$65.00M

Novo Holdings, 2150 +3

28 Feb 2022

Venture Round

$23.00M

10 Dec 2019

Debt Financing

$3.40M

03 May 2017

Seed Round

$1.50M

Acorn Innovestments

23 Dec 2015

Grant

$1.37M

National Science Foundation

21 Aug 2015

Grant

$179.92K

National Science Foundation

20 Dec 2013

Seed Round

$500.00K

09 Sep 2013

FAQ About Biomason

We build with carbon the same way nature does. Biocement will reduce 25% of the concrete industry's emissions by 2030.

Biomason was founded in 2012.

Biomason is headquartered in United States.

Biomason operates in Biotechnology, Industrial and Manufacturing. Its work centres on biocement, building materials technology, carbon emissions and construction industry.

Biomason has approximately 67 employees.

Biomason has completed 7 funding rounds, raising a total of $94.95M. The latest funding stage is Series C.

Top alternatives and competitors to Biomason include ZymoChem, Plantd, Fast-Form Systems Ltd, Geopolymer Solutions, Epsilyte. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Biomason and ZymoChem are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Biomason

Funding Rounds & Investors (7)

Latest News

Biomason Alternatives & Competitors

FAQ About Biomason